Psychiatr. pro Praxi, 2005; 2: 100-103

Vývoj dávkování quetiapinu v klinické praxi - Dogma, nebo doporučení?

MUDr. Luboš Janů Ph.D
Psychiatrická klinika FN a LF UK v Plzni

Quetiapin je atypické antipsychotikum s výtečným profilem snášenlivosti. Na základě dat získaných ze studií a z klinické praxe se zdá, že jsou vhodné vyšší dávky a rychlejší titrace, než byly doporučovány dosud – cca 600 mg během 3–4 dní. V úvodní části je podán přehled vývoje dávek a návrhů titrace. Dále jsou uvedena data získaná z vybraných zařízení České republiky.

Keywords: Klíčová slova: quetiapin, dávka, titrace, schizofrenie, bipolární porucha.

Published: February 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janů L. Vývoj dávkování quetiapinu v klinické praxi - Dogma, nebo doporučení? Psychiatr. praxi. 2005;9(2):100-103.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arango C, Bobes J. Managing acute exacerbations of schizophrenia: focus on quetiapine. Curr Med Res Opin. 2004 May; 20(5): 619-26. Go to original source... Go to PubMed...
    2. Arvanitis LA, Miller BG. Multiple fixed doses of, ,Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry. 1997 Aug 15; 42(4): 233-246. Go to original source... Go to PubMed...
    3. Buckley PF. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials. Curr Med Res Opin. 2004 Sep; 20(9): 1357-1363. Go to original source... Go to PubMed...
    4. Calabrese W, McFadden W, McCoy R, Minkwitz M, Wilson E, Mullen J. Double-blind, placebo-controlled study of quetiapine in bipolar depression. Poster presented at the XXIV Collegium Internationale Neuropsychopharmacologicum 2004. Paris, Francie. Go to original source...
    5. Citrome L, Volavka J. Optimal dosing of atypical antipsychotics in adults: a review of the current. Harv Rev Psychiatry. 2002 Sep-Oct; 10(5): 280-291. Go to original source... Go to PubMed...
    6. Copolov DL, Link CG, Kowalcyk B. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204, 636,, Seroquel) and haloperidol in schizophrenia. Psychol Med. 2000 Jan;30(1):95-105. Erratum in: Psychol Med 2000 Jul; 30(4) :991. Go to original source... Go to PubMed...
    7. Emsley RA, Raniwalla J, Bailey PJ, Jones AM. A comparison of the effects of quetiapine (seroquel) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group. Int Clin Psychopharmacol. 2000 May; 15(3): 121-131. Go to original source... Go to PubMed...
    8. Gutierrez B, Zhao Z, Wang PF, Gaylord B. Dosing of Atypical Aantipsychotics for Inpatients with Schizophrenia. Poster presented at the 55th Institut on Psychiatric Services, Boston, USA, 2003.
    9. de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry. 2003 Feb; 160(2): 303-309. Go to original source... Go to PubMed...
    10. Kapur S, Mamo D. Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct; 27(7): 1081-1090. Go to original source... Go to PubMed...
    11. Kapur S, Seeman P. Does fast dissociation from the dopamin D2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 2001, 158: 3, 360-369. Go to original source... Go to PubMed...
    12. Kapur S, Zipurski R, Jones C, Shammi CS, Remington G, Seeman P. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antispsychotics effect with only transiently high D2 receptor occupancy levels. Psychiatr Res Neuroimaging 1997: 75: 91-101.
    13. Kasper S, Müller-Spahn F. Review of Quetiapine and its Clinical appliactions in schizophrenia. Exp. Opin. Pharmacother 2000; 1 (4): 783-801. Go to original source... Go to PubMed...
    14. Keks NA, Tonso M, Tabone K, McHugh M, Thomas R, Thune P, Gelman M. Clinical experiences with the atypical antipsychotic quetiapine (´Seroquel´) in the acute inpatient unit. Poster at the XXIV Collegium Internationale Neuropsychopharmacologicum 2004. Paris, Francie.
    15. Kinon BJ, Ahl J, Stauffer VL, Hill AL, Buckley PF. Dose response and atypical antipsychotics in schizophrenia. CNS Drugs. 2004; 18(9): 597-616. Go to original source... Go to PubMed...
    16. Kneghtering R, Castelein S, Bous H, van der Linde J, Bruggeman R, Kluiter H, van den Bosch R. A randomised Open-label study of the Impact of quetiapine versus risperidone on sexual functioning. Poster Deutsche Gesselschaft für Psychiatrie, Psychotherapie, und Nervenheilkunde (DGPPN), 2003, Berlin. Go to original source...
    17. Kopala L, Milliken H, Whitehorn D, Rui Q, Woodley, Good KP. Long-term clinical effectiveness of quetiapine in first-episode psychosis. The Journal of the European College of Neuropsychopharmacology. Volume 14, Supplement 3, Page S266.
    18. Mullen JA, Devine NA, Sweitzer: Quetiapine versus placebo as adjunct to lithium or divalproex for the treatment of bipolar mania. Poster presented at the APA 17-22 5 California, 2003.
    19. Nagy J. Short-term benefits of higher-dose of quetiapine (´Seroquel´) (up to 1600 mg/day) are maintenaned in the long term. Poster presented at the XXIV Collegium Internationale Neuropsychopharmacologicum 2004. Paris, Francie.
    20. Paulsson B, Huizar K. Quetiapine monotherapy for the treatment of bipolar mania. Poster presented at the Fifth International Conference of Bipolar Disorder June 12-14 Pittsburg 2003.
    21. Pierre JM, et al. High dose quetiapine in treatment refractory schizophrenia. Biological Psychiatry 2003;53(8 Suppl S): 188S, Abs 532. Go to original source...
    22. Riedel M, Müller N, Strassnig M, Spellmann I, Müller-Arends A, Dehning S, Sadowsky N, Müller H-J. Quetiapine (´Seroquel´) has equivalent efficacy and superior tolerability to risperidone in the treating the negative symptoms of schizophrenia. Poster presented at the XXIV Collegium Internationale Neuropsychopharmacologicum 2004. Paris, Francie. Go to original source...
    23. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry. 1997 Jun; 54(6): 549-557. Go to original source... Go to PubMed...
    24. Sachetti E, Valsecchi P, Regini C, Galluzo A, Cacchiani C, Agrini E, Mancacchi C. Comparison of quetiapine (´Seroquel´) olanzapine and risperidone in a randomised study in patient with schizophrenia. Poster presented at the XXIV Collegium Internationale Neuropsychopharmacologicum 2004. Paris, Francie.
    25. Sachs G, Chengappa KNR, Suppes T, Mullen JA, Brecher M, Devine NA, Schweitzer DE. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disorders 2004: 6: 213-223. Go to original source... Go to PubMed...
    26. Simons, et al 2001, White RE. Poster presented at the 23rd Collegium Internationale NeuroPsychopharmacologicum, Montreal, Canada 2002.
    27. Smith M, McCoy R, Hamer J, Brecher M. Optimal titration for quetiapine: pilot trial. Poster presented at the New Clinical drug evaluation Unit Annual Meeting, Boca Raton, Florida USA 2002.
    28. Small JG, Kolar MC, Kellams JJ. Quetiapine in schizophrenia: onset of actuion within the first week of treatment. Curr Med Res Opin 2004: 20 (7): 1017-1023. Go to original source... Go to PubMed...
    29. Tandon: Presentation at the Annual Meeting of the American Psychiatric Association, 2004, New York, USA.
    30. Vieta E, Goldberg JF, Mullen J. Effective dose of quetiapine in the treatment of bipolar mania. Poster presented at the XXIV Collegium Internationale Neuropsychopharmacologicum 2004. Paris, Francie.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.